CJC-1295 with DAC vs CJC-1295 (No DAC) — Peptide Comparison

CJC-1295 with DAC vs CJC-1295 (No DAC) — Peptide Comparison CJC-1295 with DAC vs CJC-1295 (No DAC) — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range CJC-1295 with DAC 1000–2000 mcg CJC-1295 (No DAC) 100–300 mcg Frequency Twice weekly Once daily Administration Subcutaneous injection Cycle Length 8-12 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1-2) Efficacy GH Elevation Convenience Recovery Support GH Stimulation Sleep Quality Technical Data Molecular Formula C165H269N47O46 Molecular Weight 3647.28 g/mol Half-Life 6-8 days Bioavailability ~100% (subcutaneous) CAS Number 863288-34-0 C152H252N44O42 3367.9 g/mol 30 minutes to 2 hours Protocols starting 1 mg (1000 mcg) Once weekly 2-4 weeks A starting dose used in practice. The DAC version is long-acting (about a 6-8 day half-life), so weekly dosing keeps growth hormone and IGF-1 raised. In the Phase 1 trial a single dose raised GH for 6+ days and IGF-1 for up to 11 days. [2] standard 2 mg (2000 mcg) Once weekly (or split twice weekly) The common maintenance dose, roughly in line with the 30-60 mcg/kg weekly range studied in the Phase 1 trial. [1][2] advanced 2 mg per dose A higher total weekly amount split into two doses, used by experienced users; near the top of the 30-60 mcg/kg weekly range from the clinical study. [2] 100 mcg Once daily, 30 minutes before bed A common starting dose used in research practice. Because the no-DAC form is short-acting (about 30 minute half-life), it is injected on an empty stomach for the best growth-hormone pulse. [1] 100 mcg per dose 1-2 times daily The typical maintenance dose used in practice, often given before bed and/or after fasted exercise. Frequently paired with a GH-releasing peptide. [1] 2-3 times daily A higher-frequency plan used by experienced users to mimic natural GH pulses across the day, each dose taken fasted. [1] Applications Growth Hormone Optimization CJC-1295 with DAC excels at providing a sustained, steady elevation of growth hormone levels. Unlike shorter-acting peptides that create brief spikes, the DAC modification keeps GH elevated for days, mimicking a more youthful hormone profile. Muscle Building and Recovery By increasing both GH and IGF-1 levels, this peptide supports protein synthesis and muscle repair. Users often notice improved recovery between workouts and better ability to build and maintain lean muscle mass. Anti-Aging and Longevity Growth hormone naturally declines with age, contributing to many signs of aging. CJC-1295 with DAC helps restore more youthful GH levels, potentially supporting better skin quality, energy levels, and overall vitality. Body Composition Improvement The combination of increased GH and IGF-1 promotes fat metabolism while preserving muscle tissue. Many users experience gradual fat loss, particularly in stubborn areas, while maintaining or building lean mass. Convenient Weekly Dosing Unlike peptides requiring daily or twice-daily injections, the extended half-life of CJC-1295 with DAC means just one or two injections per week provide continuous benefits. Ideal for those who want results without daily protocols. Natural Growth Hormone Optimization Perfect for those wanting to boost their body's own GH production rather than using synthetic growth hormone. Mimics the natural pulsatile release pattern your pituitary uses. Workout Recovery and Muscle Building Athletes and fitness enthusiasts use it to accelerate recovery between training sessions, support lean muscle development, and reduce body fat over time. Sleep Quality Enhancement Because GH is naturally released during deep sleep, many users report dramatically improved sleep quality with more vivid dreams and feeling more refreshed upon waking. Anti-Aging and Vitality As GH levels decline with age, CJC-1295 helps restore more youthful hormone patterns, potentially improving skin quality, energy levels, and overall well-being. Synergistic Peptide Stacking Designed to work hand-in-hand with GHRPs like Ipamorelin. When combined, these peptides amplify each other's effects for significantly greater GH release than either alone. Safety Profile Common Injection site reactions Water retention Flushing Tingling sensation Uncommon Headaches Fatigue or lethargy Joint discomfort Serious Carpal tunnel symptoms Blood glucose elevation Flushing or warmth Increased appetite Tingling or numbness Headache Allergic reaction Research Status FDA Status Research compound Safety Overview CJC-1295 with DAC was evaluated in Phase 1-2 human clinical trials where it demonstrated a generally favorable safety profile. The most common adverse events were mild injection site reactions including temporary pain, swelling, and redness. No serious adverse events were reported in the published clinical studies. The compound was being developed for HIV-associated lipodystrophy before the program was discontinued. Contraindications xActive cancer or history of malignancy xPregnancy or breastfeeding xPituitary tumors or disorders xDiabetic retinopathy xUncontrolled diabetes CJC-1295 without DAC has been studied in Phase 1-2 human clinical trials with a favorable safety profile. The most common side effects are mild and include injection site reactions and temporary flushing. Because it stimulates natural GH release rather than providing exogenous GH, it maintains the body's feedback mechanisms. xActive cancer or history of cancer xHypersensitivity to GHRH analogs Decision Guide Choose CJC-1295 with DAC if... Boosting natural growth hormone production Building lean muscle mass Improving body composition Anti-aging and longevity Choose CJC-1295 (No DAC) if... Increasing natural growth hormone levels Improving sleep quality Enhancing workout recovery